Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Agostini

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migrationH T Agostini, R Yanagihara, V Davis, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 19, 2006
Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implantsA Mori, G Lo Russo, T Agostini, et al.
Eye (London, England)|April 12, 2014
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMDC Ehlken, S Jungmann, D Böhringer, et al.
Current Opinion in Ophthalmology|April 16, 2010
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic reviewChristine Schmucker, Christoph Ehlken, Lutz L Hansen, et al.
American Journal of Physical Anthropology|May 16, 2002
Strains of JC virus in Amerind-speakers of North America (Salish) and South America (Guaraní), Na-Dene-speakers of New Mexico (Navajo), and modern Japanese suggest links through an ancestral Asian populationMariana Fernandez-Cobo, Hansjürgen T Agostini, Graciela Britez, et al.
The Journal of Infectious Diseases|July 1, 1997
JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PMLH T Agostini, C F Ryschkewitsch, R Mory, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 23, 2006
Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinoloneT Kube, M Sutter, R Trittler, et al.
Archives of Virology|January 1, 1997
Five complete genomes of JC virus type 3 from Africans and African AmericansH T Agostini, C F Ryschkewitsch, G R Brubaker, et al.
Retina (Philadelphia, Pa.)|May 11, 2017
TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE: Identification of Health Care Constraints in Germany-The PONS StudyChristoph Ehlken, Thomas Wilke, Ulrike Bauer-Steinhusen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2009
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesisAndreas Stahl, Lilija Paschek, Gottfried Martin, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Asian genotypes of JC virus in Native Americans and in a Pacific Island population: markers of viral evolution and human migrationH T Agostini, R Yanagihara, V Davis, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|October 19, 2006
Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implantsA Mori, G Lo Russo, T Agostini, et al.
Eye (London, England)|April 12, 2014
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMDC Ehlken, S Jungmann, D Böhringer, et al.
Current Opinion in Ophthalmology|April 16, 2010
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic reviewChristine Schmucker, Christoph Ehlken, Lutz L Hansen, et al.
American Journal of Physical Anthropology|May 16, 2002
Strains of JC virus in Amerind-speakers of North America (Salish) and South America (Guaraní), Na-Dene-speakers of New Mexico (Navajo), and modern Japanese suggest links through an ancestral Asian populationMariana Fernandez-Cobo, Hansjürgen T Agostini, Graciela Britez, et al.
The Journal of Infectious Diseases|July 1, 1997
JC virus (JCV) genotypes in brain tissue from patients with progressive multifocal leukoencephalopathy (PML) and in urine from controls without PML: increased frequency of JCV type 2 in PMLH T Agostini, C F Ryschkewitsch, R Mory, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|May 23, 2006
Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinoloneT Kube, M Sutter, R Trittler, et al.
Archives of Virology|January 1, 1997
Five complete genomes of JC virus type 3 from Africans and African AmericansH T Agostini, C F Ryschkewitsch, G R Brubaker, et al.
Retina (Philadelphia, Pa.)|May 11, 2017
TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITORS IN EVERYDAY PRACTICE: Identification of Health Care Constraints in Germany-The PONS StudyChristoph Ehlken, Thomas Wilke, Ulrike Bauer-Steinhusen, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2009
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesisAndreas Stahl, Lilija Paschek, Gottfried Martin, et al.
Pageof 11